🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
1.320
-0.120 (-8.33%)
At close: Nov 20, 2026, 4:00 PM EST
1.600
+0.280 (21.21%)
After-hours: Nov 20, 2026, 6:26 PM EST

DarioHealth Statistics

Total Valuation

DarioHealth has a market cap or net worth of $14.90 million. The enterprise value is $16.21 million.

Market Cap14.90M
Enterprise Value 16.21M

Important Dates

The last earnings date was Thursday, November 12, 2026, before market open.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

DarioHealth has 11.29 million shares outstanding. The number of shares has increased by 222.51% in one year.

Current Share Class 11.29M
Shares Outstanding 11.29M
Shares Change (YoY) +222.51%
Shares Change (QoQ) +29.08%
Owned by Insiders (%) 20.09%
Owned by Institutions (%) 6.50%
Float 6.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.70
Forward PS 0.61
PB Ratio 0.21
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.46.

Current Ratio 4.20
Quick Ratio 3.74
Debt / Equity 0.46
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.81

Financial Efficiency

Return on equity (ROE) is -46.58% and return on invested capital (ROIC) is -18.07%.

Return on Equity (ROE) -46.58%
Return on Assets (ROA) -16.51%
Return on Invested Capital (ROIC) -18.07%
Return on Capital Employed (ROCE) -29.44%
Weighted Average Cost of Capital (WACC) 10.82%
Revenue Per Employee $129,103
Profits Per Employee -$249,263
Employee Count165
Asset Turnover 0.19
Inventory Turnover 1.96

Taxes

In the past 12 months, DarioHealth has paid $450,000 in taxes.

Income Tax 450,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.57% in the last 52 weeks. The beta is 1.18, so DarioHealth's price volatility has been higher than the market average.

Beta (5Y) 1.18
52-Week Price Change -90.57%
50-Day Moving Average 4.46
200-Day Moving Average 7.05
Relative Strength Index (RSI) 24.07
Average Volume (20 Days) 73,196

Short Selling Information

The latest short interest is 114,624, so 1.02% of the outstanding shares have been sold short.

Short Interest 114,624
Short Previous Month 81,229
Short % of Shares Out 1.02%
Short % of Float 1.75%
Short Ratio (days to cover) 2.06

Income Statement

In the last 12 months, DarioHealth had revenue of $21.30 million and -$41.13 million in losses. Loss per share was -$4.28.

Revenue21.30M
Gross Profit 13.06M
Operating Income -30.40M
Pretax Income -33.60M
Net Income -41.13M
EBITDA -28.30M
EBIT -30.40M
Loss Per Share -$4.28
Full Income Statement

Balance Sheet

The company has $31.15 million in cash and $32.46 million in debt, with a net cash position of -$1.31 million or -$0.12 per share.

Cash & Cash Equivalents 31.15M
Total Debt 32.46M
Net Cash -1.31M
Net Cash Per Share -$0.12
Equity (Book Value) 71.27M
Book Value Per Share 6.36
Working Capital 29.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.53 million and capital expenditures -$122,000, giving a free cash flow of -$23.66 million.

Operating Cash Flow -23.53M
Capital Expenditures -122,000
Depreciation & Amortization 2.10M
Net Borrowing n/a
Free Cash Flow -23.66M
FCF Per Share -$2.10
Full Cash Flow Statement

Margins

Gross margin is 61.30%, with operating and profit margins of -142.69% and -159.86%.

Gross Margin 61.30%
Operating Margin -142.69%
Pretax Margin -157.75%
Profit Margin -159.86%
EBITDA Margin -132.84%
EBIT Margin -142.69%
FCF Margin n/a

Dividends & Yields

DarioHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -222.51%
Shareholder Yield -222.51%
Earnings Yield -324.15%
FCF Yield -158.77%

Analyst Forecast

The average price target for DarioHealth is $8.00, which is 506.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 506.06%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 20.17%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date Aug 28, 2025
Split Type Reverse
Split Ratio 1:20

Scores

DarioHealth has an Altman Z-Score of -5.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.32
Piotroski F-Score 1